Abstract
Chemoresistance and increased growth rate are two gain-of-function functions that mutant p53 is thought to possess. Here, we describe two methods for measuring the sensitiveness of cells to chemotherapeutic drugs and the rate of cell growth. Both of which can be used with a wide range of cell types. The clonogenic assay can be used with many different chemotoxic drugs and the growth assay described here presents an alternative to the MTT assay and allows for a long-term measurement of cell growth. These protocols are both easy, flexible, require relatively little effort, and are inexpensive to carry out.
These authors contributed equally to this work.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Puck, T.T., Marcus, P.I. and Cieciura, S.J. (1956) Clonal growth of mammalian cells in vitro; growth characteristics of colonies from single HeLa cells with and without a feeder layer. J. Exp. Med., 103, 273–283
Puck, T.T. and Marcus, P.I. (1956) Action of x-rays on mammalian cells. J. Exp. Med., 103, 653–666
Bhana, S. and Lloyd, D.R. (2008) The role of p53 in DNA damage-mediated cytotoxicity overrides its ability to regulate nucleotide excision repair in human fibroblasts. Mutagenesis, 23, 43–50
Lin, X., Ramamurthi, K., Mishima, M., Kondo, A. and Howell, S.B. (2000) p53 interacts with the DNA mismatch repair system to modulate the cytotoxicity and mutagenicity of hydrogen peroxide. Mol. Pharmacol., 58, 1222–1229
Lu, X., Errington, J., Curtin, N.J., Lunec, J. and Newell,D.R. (2001) The impact of p53 status on cellular sensitivity to antifolate drugs. Clin. Cancer Res., 7, 2114–2123
McDonald, A.C. and Brown, R. (1998) Induction of p53-dependent and p53-independent cellular responses by topoisomerase 1 inhibitors. Br. J. Cancer, 78, 745–751
Sah, N.K., Munshi, A., Nishikawa,T., Mukhopadhyay,T., Roth,J.A. and Meyn,R.E. (2003) Adenovirus-mediated wild-type p53 radiosensitizes human tumor cells by suppressing DNA repair capacity. Molecular Cancer Therapeutics, 2, 1223–1231
Jiang, S. et al. Molecular dissection of the miR-17–92 cluster’s critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation. Blood. 2011 Oct
Stewart EA, Samaranayake GJ, Browning AC, Hopkinson A, Amoaku WM. Comparison of choroidal and retinal endothelial cells: Characteristics and response to VEGF isoforms and anti-VEGF treatments. Experimental Eye Research. 2011 Sep 28
Demars MP, Bartholomew A, Strakova Z, Lazarov O. Soluble amyloid precursor protein: a novel proliferation factor of adult progenitor cells of ectodermal and mesodermal origin. Stem Cell Res Ther. 2011 Aug 30;2(4):36
Yang J, Sun M, Zhang A, Lv C, De W, Wang Z. Adenovirus-mediated siRNA targeting Bcl-xL inhibits proliferation, reduces invasion and enhances radiosensitivity of human colorectal cancer cells. World Journal of Surgical Oncology. 2011 Oct 4;9(1):117
Anzai, K. Effectiveness of combined treatment using X-rays and a phosphoinositide 3-kinase inhibitor, ZSTK474, on proliferation of HeLa cells in vitro and in vivo. Cancer Sci. 2011 Jun; 102(6):1176–80
Johnson MD, O’Connell M, Facik M, Maurer P, Jahromi B, Pilcher W. Cerebrospinal fluid stimulates leptomeningeal and meningioma cell proliferation and activation of STAT3. Journal of Neuro-oncology. 2011 Oct
Acknowledgments
This work was supported by grants from NIH to Sumitra Deb (CA70712 and CA121144) and Swati Palit Deb (CA74172), and Pilot Project Awards from Massey Cancer to Sumitra Deb and Swati Palit Deb. We thank Shilpa Singh for help in editing this chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this protocol
Cite this protocol
Ramamoorthy, M., Vaughan, C., Deb, S., Deb, S.P. (2013). Measurement of Chemosensitivity and Growth Rate in p53 Expressing Cells. In: Deb, S., Deb, S. (eds) p53 Protocols. Methods in Molecular Biology, vol 962. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-236-0_10
Download citation
DOI: https://doi.org/10.1007/978-1-62703-236-0_10
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-235-3
Online ISBN: 978-1-62703-236-0
eBook Packages: Springer Protocols